Navigation Links
BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations

INDIANAPOLIS, Feb. 26 /PRNewswire/ -- BioStorage Technologies, Inc. (BST), announces the appointment of Dr. Wolfgang Hoffer as Managing Director of the company's European operations in Griesheim, Germany. Hoffer joins BST with nearly 20 years of management experience in the fields of clinical pharmacology and toxicology. In his new role, Hoffer will report directly to James M. Saponaro, Chief Operating Officer for BST, and will manage all aspects of BST's Europe Division, including sales and marketing, operations and finance.

Dr. Hoffer has previously held positions with MOMENTUM Pharma Services, MDS Pharma Services, PAREXEL(R) International, The Boston Consulting Group and Solvay Pharma. Most recently, he was site director of MOMENTUM Pharma Services' Hamburg, Germany, location, following its spinout from MDS Pharma Services.

"Hoffer will focus on offering worldwide service to our global pharmaceutical clients while maintaining our standards of operational excellence," said F. John Mills, M.D., Ph.D., Chief Executive Officer and Chairman of the Board.

"We were looking for someone with broad, credible experience in the pharmaceutical and contract research industry. Not only does Wolfgang have the right level of industry experience and credentials, but he also has a first- rate, entrepreneurial spirit. We wanted someone who is willing to roll up his sleeves and get things done, and he is definitely that kind of individual," said Mills.

Dr. Hoffer holds a doctorate in physiological chemistry from the University of Veterinary Medicine Hannover (Germany), and is a certified veterinarian in the German state of Bavaria. Dr. Hoffer began his educational career studying chemistry and biology at the University of Kaiserslautern (Germany).

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is a worldwide leader in sample storage, inventory management and cold-chain logistics for the biotechnology and pharmaceutical industries throughout the research, clinical trial and commercialization phases of drug development. The company offers secure, temperature-controlled storage; real-time tracking of stored biological samples; and next-day return of biomaterials. BioStorage Technologies is privately-held and headquartered in Indianapolis with an additional full- service site near Frankfurt, Germany. For more information about the company, please visit or call +1 (866) 697-2675 or +49 615 582 4490.

SOURCE BioStorage Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies Appoints Lori Ball as Vice President
2. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
3. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
4. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
5. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
6. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
7. NASA MidSTAR-1 successful technologies may be revolutionary
8. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
9. Neurobiological Technologies Sets Date for Research and Development Day
10. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc.
11. Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations
Post Your Comments:
(Date:11/23/2015)... 2015  CryoLife, Inc. (NYSE: CRY ), a leading ... vascular surgery, announced today that it will participate in the ... Wednesday, December 2, 2015 at The New York Palace Hotel ... Pat Mackin , President and Chief Executive Officer. ... --> A live webcast of the Company,s ...
(Date:11/23/2015)... 23, 2015  Oxis Biotech, Inc. (OXIS), a ... OXIS] and [Euronext Paris: OXI.PA] announced today its ... Center received notification from the U.S. Food and ... their planned combination Phase 1/Phase 2 clinical trial ... develop and commercialize OXS-1550, a novel therapy for ...
(Date:11/23/2015)... Research and Markets ( ) has announced the addition ... Application and Geography - Global forecast to 2020" report ... --> The overall service laboratory market is expected to ... Billion by 2020, at a CAGR of 6.5% from 2014 ... The market in APAC is expected to witness the ...
(Date:11/23/2015)... DUBLIN, Ireland , November 23, 2015 ... announced the addition of the  "2016 Global ... Suppliers and Emerging Market Entrants"  report to ... has announced the addition of the  "2016 ... Major Suppliers and Emerging Market Entrants"  report ...
Breaking Biology Technology:
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
(Date:10/27/2015)... Munich, Germany , ... (ASGM) automatically maps data from mobile eye tracking videos ... so that they can be quantitatively analyzed with SMI,s ... Germany , October 28-29, 2015. SMI,s Automated Semantic ... eye tracking videos created with SMI,s Eye Tracking ...
(Date:10/26/2015)... -- Delta ID Inc., a company focused on bringing secure ... announced its ActiveIRIS® technology powers the iris recognition feature ... NTT DOCOMO, INC in Japan . ... include iris recognition technology, after a very successful introduction ... 2015, world,s first smartphone to have this capability. ...
Breaking Biology News(10 mins):